Metadichol: an inhibitor of zoonotic viruses; Nipah, Lassa, and rabies

Author:

raghavan Palayaakotai R1ORCID

Affiliation:

1. Nanorx Inc

Abstract

Abstract Zoonotic viruses, such as coronaviruses, the Ebola virus, the Zika virus, Nipah, Laasa, and rabies, can be transmitted from animals to humans (1). There is a need to develop inhibitors because they can potentially prevent or treat viral infections in humans and animals (2). Metadichol® is a nanoemulsion of long-chain alcohols that is a potent inhibitor of viruses. We present the results of in vitro assays showing that it inhibits Lassa, rabies, and Nipah viruses at concentrations ranging from 0.8 to 2.6 µg/ml. It is likely that the binding of metadichol to VDR (vitamin D receptor) leads to the regulation of c-MYC (MYC Proto-Oncogene, BHLH Transcription Factor), which controls the expression of SP1 (SP1 transcription factor), which is the key step in controlling the viral replication gene GSPT1 (G1 to S Phase Transition 1). Since metadichol is commercially available and nontoxic, with an LD50 of more than 5000 mg/kg in rats, it could be useful in the treatment of such zoonotic diseases.

Publisher

Research Square Platform LLC

Reference36 articles.

1. https://link.springer.com/article/10.1007/s00232-020-00136-z.

2. https://link.springer.com/article/10.1007/s11684-017-0589-5.

3. https://www.who.int/news-room/fact-sheets/detail/zoonoses.

4. https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html

5. P R. Raghavan, "Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro", BioMed Research International, vol. 2022, Article ID 1558860, 14 pages, 2022. https://doi.org/10.1155/2022/1558860.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3